BIB icon

ProShares Ultra NASDAQ Biotechnology

11 hedge funds and large institutions have $3.58M invested in ProShares Ultra NASDAQ Biotechnology in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$15K
Net Calls
Net Calls Change

Top Buyers

1 +$602K
2 +$491K
3 +$254K
4
Jane Street
Jane Street
New York
+$231K
5
GT
Glenmede Trust
Pennsylvania
+$18.1K

Top Sellers

1 -$998K
2 -$36K
3 -$31.8K
4
Creative Planning
Creative Planning
Kansas
-$28.9K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.23M
2
$1.14M
3
$491K
4
$254K
5
$231K
6
$161K
7
$35K
8
$18K
9
$13K
10
$5K
11
$3K
12
13